In 2018, Novartis set the ambition to become a leading medicines company powered by data and digital technologies. To realize this goal, the newly appointed Chief Executive Officer (CEO), Vasant Narasimhan, set Data and Digital Leadership as one of Novartis’ five strategic priorities. As part of the new digital strategy, Bertrand Bodson, known for turning Argos from a traditional catalogue retailer to one of the third largest online retailers in the UK, was hired as its new Chief Digital Officer (CDO). Bodson arrived on the pharmaceuticals scene in the midst of exciting but also challenging times: science, technology and data were converging, progressing by leap and bounds and presenting new breakthrough opportunities. At the same time, the pharmaceutical industry was evolving, and both competitors and other players in the ecosystem were getting more sophisticated. Bodson needed to act quickly. Pharma was being disrupted and he needed to align the organization and capture the new opportunities. How could he get Novartis digitally ready?
- Explore the role and qualities of a CDO.
- Examine what a digital transformation could entail in a multinational corporation
- Analyze factors for successes and failures in digital transformations
Novartis, Health Care, Pharmaceuticals
IMD retains all proprietary interests in its case studies and notes. Without prior written permission, IMD cases and notes may not be reproduced, used, translated, included in books or other publications, distributed in any form or by any means, stored in a database or in other retrieval systems. For additional copyright information related to case studies, please contact Case Services.
Research Information & Knowledge Hub for additional information on IMD publications